Exosome-mediated siRNA delivery in cancer: Loading strategies, targeting approaches, and therapeutic outcomes
DARU, Journal of Pharmaceutical Sciences · Published 2026-08-03 · DOI 10.1007/s40199-026-00631-z
Free full text
Authors (10)
Amr Ali Mohamed Abdelgawwad El-Sehrawy, Hassan Youssef Hussein, Ozodbek Nematov, Mirza R. Baig, Dhara N. Patel, Priya Priyadarshini Nayak, Safa Alkayyat, Neeraj Bainsal, Gunjan Singh, Tina Saeed Basunduwah
Abstract
PubPorta does not have an abstract for this article yet.
Read the article at the publisher →
Publication details
- Year
- 2026
Citation
El-Sehrawy, A., Hussein, H., Nematov, O., et al. (2026). Exosome-mediated siRNA delivery in cancer: Loading strategies, targeting approaches, and therapeutic outcomes. DARU, Journal of Pharmaceutical Sciences. https://doi.org/10.1007/s40199-026-00631-z
Related articles
- Exosome engineering for targeted therapy of brain-infecting pathogens: molecular tools, delivery platforms, and translational advances · Frontiers in Medical Technology · 2025 · Cites or is cited by this article
- The effect of Fe3O4 biosynthesized through the green synthesis of Silybum marianum and HA in the targeted delivery of 5-Fluorouracil to HCT116 cell line · DARU, Journal of Pharmaceutical Sciences · 2025 · Same journal
- Tableting of nanoparticle-based formulations for oral delivery: Enhancing biopharmaceutical performance · DARU, Journal of Pharmaceutical Sciences · 2026 · Same journal
- Advances in nanostructured drug delivery systems for cardiovascular therapeutics · DARU, Journal of Pharmaceutical Sciences · 2025 · Same journal
- Poly (lactic-co-glycolic acid) nanoplatforms for triple-negative breast cancer: current progress, advances, and future outlook · DARU, Journal of Pharmaceutical Sciences · 2026 · Same journal
- Eugenol mitigates schizophrenia-like behavioral deficits, oxidative stress, apoptosis, neuroinflammation, and cholinergic dysfunction in ketamine-induced mice · DARU, Journal of Pharmaceutical Sciences · 2026 · Same journal
- Plant-derived exosome-like nanovesicles as programmable bio-organic excipients: a next-generation platform for precision and immuno-silent drug delivery · DARU, Journal of Pharmaceutical Sciences · 2026 · Same journal
- Deep fused explainable neural architecture for the automatic recognition of therapeutic medicinal plants · DARU, Journal of Pharmaceutical Sciences · 2026 · Same journal
- Novel 3,3′-diindolylmethane derivatives as multi-pathway modulators: targeting estrogen-dependent and independent breast cancer carcinogenesis · DARU, Journal of Pharmaceutical Sciences · 2026 · Same journal
- Co-delivery of SN38 and rapamycin albumin bound nanoparticles against breast Cancer · DARU, Journal of Pharmaceutical Sciences · 2025 · Same journal